alexa Medication Reviews By Pharmacists As A Means Of Reducing Medication Errors And Improving Patient Outcomes: Current Challenges And Opportunities | 13260
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

Medication reviews by pharmacists as a means of reducing medication errors and improving patient outcomes: Current challenges and opportunities

International Summit on Clinical Pharmacy & Dispensing

Helen C. Gallagher

ScientificTracks Abstracts: Clinic Pharmacol Biopharmaceut

DOI: 10.4172/2167-065X.S1.002

Abstract
Regular medication review is recommended for elderly patients and those on multiple drug therapy. The overall objective of such reviews is to ensure that drugs are prescribed and used appropriately and that patients are deriving maximum benefit from their drug regimes. As such, medication review requires knowledge of a patient's medical problems that are treatable with medicines, the medicines that are prescribed for those problems, and an appreciation of the patient's level of understanding and adherence with that medicine. It is increasingly recognised that pharmacists should be involved in the process of medication review if the patient is to receive optimal pharmaceutical care. There are numerous examples of clinical scenarios in which pharmacist-led medication review has improved patient adherence patterns and clinical outcomes. Overall, it appears that the professional expertise of pharmacists in conducting medication reviews can be demonstrated most clearly in discrete disease areas/clinical scenarios. Well-designed, randomized studies in which outcome measures are rather narrowly defined (eg blood pressure or blood sugar indices) appear to be more likely to indicate positive benefits of medication review, whereas generalised outcomes such as mortality, morbidity and quality of life appear more resistant to such interventions. This has provoked serious debate in the literature, much of which pits the professions of pharmacy and medicine against each other. Here, evidence for the benefit of medication reviews by pharmacists is reviewed and discussed with the aim of identifying confounding factors that are currently hindering progress in this important area of pharmacy practice.
Biography
Helen C. Gallagher B.Sc. (Hons), B. Pharm., M.Pharm., Ph.D., MPSI, holds degrees in Pharmacology and Pharmacy from University College Dublin, Trinity College Dublin & The Royal College of Surgeons in Ireland. She is a Lecturer in the School of Medicine and Medical Science, University College Dublin, Ireland, and works part-time as a Community Pharmacist. Her main research interests are in the areas of anaesthetics/ pain medicine, neuropharmacology & pharmaceutical care. She is currently the recipient of a Cochrane Fellowship from the Health Research Board of Ireland and a member of the Cochrane Pain, Palliative & Supportive Care Review Group.
Top